Chimeric Therapeutics Limited
$0.005
+$0.00 (+0.00%) Day
1 day chart
Get A$10 trading credit to start you off
Sign up and fund a new Stake AUS account and enjoy an extra A$10 trading credit on us.
Sign up and fund a new Stake AUS account and get A$10 bonus trading credit.
T&Cs apply
About CHM
Chimeric Therapeutics Limited (CHM) is a clinical stage cell therapy company focused on developing and commercialising a range of cell therapies in oncology. Lead products under development by the group are T Cell Derived Autologous Therapies as well as Natural Killer (NK) Cell Derived Allogenic Therapies
Find out what a historical investment in Chimeric Therapeutics Limited would be worth today using our CHM stock calculator.
Sector
Health Care
CEO
-
Industry
Biotechnology
Website
chimerictherapeutics.com
$8M
-0.28
-
$0.01
$0.00
$0.01
$0.03
$0.00
Ready to start your investing journey with Stake?
Open an accountAnnouncements
EMORY JOINS CHM CDH17 PHASE 1/2 CLINICAL TRIAL
Thu, Apr 24, 2025
Completion of Entitlement Offer
Wed, Apr 23, 2025
Quarterly Activities/Appendix 4C Cash Flow Report
Tue, Apr 22, 2025
CHM FAQs
- Sign up with some I.D. and zero paperwork
- Add funds to your account
- Make your first investment in CHM
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.
Invest in CHM
on Stake
Buy CHM from A$3 brokerage
Invest in 2,500+ Aussie stocks and ETFs
CHESS-sponsored ASX trades
